Jens Bjørheim
Chief Tech/Sci/R&D Officer at ULTIMOVACS ASA
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Audun Tornes | M | - | - | |
| Carlos de Sousa | M | 66 | 4 years | |
| Giuditta Cordero-Moss | M | 61 |
University of Oslo
| 28 years |
| Hans Vassgård Eid | M | 57 | - | |
| Anne Hovi Worsøe | F | 60 | 3 years | |
| Gudrun Trøite | M | - | - | |
| Kari Grønås | F | 59 | 5 years | |
| Ingunn Hagen Westgaard | F | - | - | |
| Haakon Stenrod | M | 44 | 4 years | |
| Antonius Berkien | M | 56 | 4 years | |
| Bjørn Steen Skålhegg | M | 65 |
University of Oslo
| 23 years |
| Gustav Gaudernack | M | - | - | |
| Øivind Foss | M | - | - | |
| Kjetil Taskén | M | 59 |
University of Oslo
| 23 years |
| Henrik Schüssler | M | 61 | 9 years | |
| Jónas Einarsson | M | 67 | 13 years | |
| Mc Callion Orla | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hilde Hermansen Steineger | M | 58 |
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway.
University of Oslo
| 12 years |
| Morten Jurs | M | 64 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | - |
| Camilla Sandberg | F | 57 |
University of Oslo
| 6 years |
| Daniel Ras-Vidal | M | - |
University of Oslo
| 4 years |
| Göran Gannedahl | M | 71 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | - |
| Trygve Burchardt | M | - |
University of Oslo
| 8 years |
| Hans Ivar Robinson | M | 57 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | 2 years |
| Viktor Sigurd Wold Eide | M | 53 |
University of Oslo
| 5 years |
| Nils Arne Grønlie | M | - |
University of Oslo
| 3 years |
| Håvard Vikse | M | - |
University of Oslo
| 4 years |
| Kristin Hellebust | F | - |
University of Oslo
| 1 years |
| Robin Bakken | M | 48 |
University of Oslo
| 3 years |
| Camilla Elisabeth Magnus | F | 52 |
University of Oslo
| 3 years |
| Adele Bugge Norman Pran | F | 54 |
University of Oslo
| 3 years |
| Stephan Michal Wold Eide | M | 55 |
University of Oslo
| 3 years |
| Hege Schøyen Dillner | F | 57 |
University of Oslo
| 1 years |
| Lilly Tønnevold Stakkeland | F | 69 |
University of Oslo
| 1 years |
| Henrik Inadomi | M | - |
University of Oslo
| 4 years |
| Anne Kristin Holmeide | M | 56 |
University of Oslo
| 3 years |
| Wenche Margaretha Seljeseth | F | 60 |
University of Oslo
| 3 years |
| Randi Haugaa | F | 55 |
University of Oslo
| 6 years |
| Marianne Langrind Kvanvik | F | 50 |
University of Oslo
| 3 years |
| Anita Høst | F | - |
University of Oslo
| 3 years |
| Cecilie Grue | F | 54 |
University of Oslo
| 1 years |
| Bjørn Petter Lindhom | M | - |
University of Oslo
| 1 years |
| Hanne Ringnes Sanne | F | - |
University of Oslo
| 3 years |
| Line Johnsen | M | - |
University of Oslo
| 3 years |
| Jens Lindberg | M | 53 |
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | 5 years |
| Karoline W. Schjetne | M | - |
University of Oslo
| 3 years |
| Mette Husbyn | M | - |
University of Oslo
| 3 years |
| Andreas Kveil Slettvoll | M | - |
University of Oslo
| 5 years |
| Marianne Thorsdal | F | 61 |
University of Oslo
| 4 years |
| Inger Grete Lundemo | M | 51 |
University of Oslo
| 1 years |
| Sindre Svendsen Østgård | M | - |
University of Oslo
| 2 years |
| Kristine Larneng | F | 42 |
University of Oslo
| 6 years |
| Nils Holger Koefoed | M | - |
University of Oslo
| 1 years |
| Tore Sande | M | 55 |
University of Oslo
| 3 years |
| Runar Wiik | M | 46 |
University of Oslo
| 3 years |
| Jostein Dahle | M | 51 |
University of Oslo
| 3 years |
| Anine Tennøe Ramm | F | 46 |
University of Oslo
| 3 years |
| Inga Kaasen | M | 66 |
University of Oslo
| 3 years |
| Felix Reimers | M | - |
University of Oslo
| 3 years |
| Norbert Hoyer | M | - |
University of Oslo
| 3 years |
| Anne Kjølseth | F | - |
University of Oslo
| 4 years |
| Jo Erik Johnsrud Klaveness | M | 71 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | - |
| Siri Fürst | F | 66 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | - |
| Ole Dahlberg | M | - |
University of Oslo
| 1 years |
| Tarik Cicic | M | - |
University of Oslo
| 3 years |
| Gulden Tobias Dahl | M | - |
University of Oslo
| 3 years |
| Nini Eugenie Høegh Nergaard | F | 52 |
University of Oslo
| 6 years |
| Trygve Christophersen | M | 65 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | - |
| Jo Olav Lunder | M | 62 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | 5 years |
| Rikke Kathrine Tobi Reinemo | F | 49 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | - |
| Christen Krogh | M | - |
University of Oslo
| 3 years |
| Håvard Hildeng Hauge | M | 55 |
University of Oslo
| 3 years |
| Håkon Wium Lie | M | - |
University of Oslo
| 3 years |
| Haakon Bryhni | M | 56 |
University of Oslo
| 3 years |
| Marianne Heien Blystad | F | 66 |
University of Oslo
| 3 years |
| Iacob Mathiesen | M | 57 |
University of Oslo
| 3 years |
| Børge Grøttjord | M | - |
University of Oslo
| 3 years |
| Martin Nes | M | 55 |
University of Oslo
| 3 years |
| Mari Rege | M | 50 |
University of Oslo
| 3 years |
| Britt Kjelleberg | F | 46 |
University of Oslo
| 3 years |
| Ingunn Carelius | M | - |
University of Oslo
| 1 years |
| May Arna Risberg | M | - |
University of Oslo
| 3 years |
| Erik Helstad | M | 57 |
University of Oslo
| 3 years |
| Daniel Kjørberg Siraj | M | 49 |
University of Oslo
| 3 years |
| Thomas Rygg Hannestad | M | 54 |
University of Oslo
| 3 years |
| Unni Marie Rådalen | F | 53 |
University of Oslo
| 9 years |
| Christopher William Ihlen | M | 56 |
University of Oslo
| 6 years |
| Benedicte Teigen Gude | F | 53 |
University of Oslo
| 1 years |
| Torild Skogsholm | F | 65 |
University of Oslo
| 4 years |
| Charlotte Berg-Svendsen | F | 49 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | - |
| Bettina Banoun | M | 52 |
University of Oslo
| 3 years |
| Edith Rian | M | 58 |
University of Oslo
| 3 years |
| Bjørn Næss | M | - |
University of Oslo
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Norway | 92 | 98.92% |
| Denmark | 1 | 1.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jens Bjørheim
- Personal Network
